Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Proceedings of the National Academy of Sciences of the United States of America|April 12, 2022
MicroRNA networks in FLT3-ITD acute myeloid leukemiaDinh Hoa Hoang, Dandan Zhao, Sergio Branciamore, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 2, 2015
Influence of Absorption, Distribution, Metabolism, and Excretion Genomic Variants on Tacrolimus/Sirolimus Blood Levels and Graft-versus-Host Disease after Allogeneic Hematopoietic Cell TransplantationSamer K Khaled, Joycelynne M Palmer, Josef Herzog, et al.
Bone Marrow Transplantation|September 25, 2012
A phase II study of sirolimus, tacrolimus and rabbit anti-thymocyte globulin as GVHD prophylaxis after unrelated-donor PBSC transplantS K Khaled, J Palmer, T Stiller, et al.
Transplantation and Cellular Therapy|October 5, 2020
Clinical Outcomes in Patients with FLT3-ITD-Mutated Relapsed/Refractory Acute Myelogenous Leukemia Undergoing Hematopoietic Stem Cell Transplantation after Quizartinib or Salvage Chemotherapy in the QuANTUM-R TrialSiddhartha Ganguly, Jorge E Cortes, Alwin Krämer, et al.
Blood Advances|February 15, 2019
Pracinostat plus azacitidine in older patients with newly diagnosed acute myeloid leukemia: results of a phase 2 studyGuillermo Garcia-Manero, Yasmin Abaza, Koichi Takahashi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2022
Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALLIbrahim Aldoss, Samer K Khaled, Xiuli Wang, et al.
Blood|April 28, 2016
Phase 1 studies of central memory-derived CD19 CAR T-cell therapy following autologous HSCT in patients with B-cell NHLXiuli Wang, Leslie L Popplewell, Jamie R Wagner, et al.
Haematologica|October 4, 2017
Favorable impact of allogeneic stem cell transplantation in patients with therapy-related myelodysplasia regardless of <i>TP53</i> mutational statusIbrahim Aldoss, Anh Pham, Sierra Min Li, et al.
Pageof 2